AMPLY Discovery

Private

BelfastHealthcare & Life Scienceshttps://amplydiscovery.com/

Last Round

Strategic

Feb 11, 2026

Total Funding Raised

$4.33M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AMPLY Discovery is a biotechnology company that uses its proprietary AI platform, AMPLYfolioAI, to discover novel biologic drugs for diseases such as cancer and drug-resistant infections.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

ai drug discoverybiologic drug discoverygenerative biologysynthetic biologyai discovery platformAI for biologyRNAi therapyantimicrobial peptidesAMPsin-silico discoverynext-generation sequencingNGSdrug candidate licensingoncology drug discoverydrug-resistant infection therapydrug discovery studiobio-printing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMPLY Discovery Comps

Public and private peers based on sector, stage, and business model.

AMPLY Discovery comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AMPLY Discovery Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	Feb 11, 2026
Seed	May 1, 2025
Grant	Feb 12, 2024
Accelerator	Dec 9, 2023
Pre Seed	Sep 27, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Ben Thomas

Chief Executive Officer

Executive Team

AMPLY Discovery Investors

Notable investors and investment history

AMPLY Discovery investors
Investor	Rounds
Venture Science	Seed
QUBIS	Seed, Pre Seed
Techstars	Accelerator
British Business Bank	Seed, Pre Seed
Invest Northern Ireland	Pre Seed
The Helix Way Partnership	Pre Seed
Clarendon Fund Managers	Seed, Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 11, 2026
Raised a strategic round with Keeps Biomed participating.
Jul 7, 2025
Monthly visitors grew 124% MoM, reaching 1.4K.

View all signals

AMPLY Discovery Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AMPLY Discovery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMPLY Discovery's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelfast

Employee Range7

Year Founded2021

Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.